Brief: Hungary's Richter acquires women’s health discovery portfolio of U.S.-based Celmatix
03/03/2026 07:03
March 3 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: ACQUIRES WOMEN’S HEALTH DISCOVERY PORTFOLIO OF US BASED CELMATIX CELMATIX WILL RECEIVE AN UPFRONT PAYMENT AND WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT MILESTONE PAYMENT DEVELOPMENT OF THE ACQUIRED PROGRAMS WILL BE LED BY THE WOMEN'S HEALTH ORIGINAL R&D HUB OF RICHTER IN BELGIUM Source text: [https://www.bse.hu/newkibdata/129409975/Richter_Celmatix_Mar2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection